We remain upbeat outlook for Fisher & Paykel

We remain upbeat outlook for Fisher & Paykel. Respiratory equipment manufacturer, Fisher & Paykel Healthcare, continued its steady rise during the month (+7.8%) bringing its total return to 41.3% for the calendar year to date. Members of the team recently met up with management in New Zealand and in the US and toured the company's new manufacturing facility in Mexico where it plans to expand production space by 66% to provide capacity for growing sales in both the hospital and in-home markets. We remain upbeat about the company's long-term prospects despite the strong share price performance.
Welcome to Livewire, Australia’s most trusted source of investment insights and analysis.
To continue reading this wire and get unlimited access to Livewire, join for free now and become a more informed and confident investor.


OC Funds Management (OC) is a boutique small cap specialist which was founded by its investment staff and non-executive directors. OC commenced operated in December 2000 with the launch of two long only small cap Australian equity funds, the OC...
Expertise
No areas of expertise

OC Funds Management (OC) is a boutique small cap specialist which was founded by its investment staff and non-executive directors. OC commenced operated in December 2000 with the launch of two long only small cap Australian equity funds, the OC...
Expertise
No areas of expertise
Please sign in to comment on this wire.